The company's asset efficiency, represented by a robust -2.545% return, is a testament to Bone Biologics Corporation's adeptness in optimizing resource deployment. Bone Biologics Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -2.509%. Furthermore, the proficiency of Bone Biologics Corporation in capital utilization is underscored by a remarkable -3.244% return on capital employed.
Stock Prices
Bone Biologics Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.69, while its low point bottomed out at $1.55. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Bone Biologics Corporation's stock market.
Liquidity Ratios
Analyzing BBLG liquidity ratios reveals its financial health of the firm.
The current ratio of 449.57% gauges short-term asset coverage for liabilities.
The quick ratio (403.58%) assesses immediate liquidity, while the cash ratio (364.03%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
449.57%
Quick Ratio
403.58%
Cash Ratio
364.03%
Profitability Ratios
The effective tax rate stands at -6.25%, revealing its tax efficiency.
The net income per EBT, 106.28%, and the EBT per EBIT, 94.91%, provide insights into its earnings hierarchy.
cards.indicator
cards.value
Effective Tax Rate
-6.25%
Net Income per EBT
106.28%
EBT per EBIT
94.91%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 4.50, it details the span from stock purchase to revenue.
The 4 days it takes to settle debts showcases its creditor relations.
cards.indicator
cards.value
Days of Sales Outstanding
404
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -17.89, and free cash flow per share, -17.89, depict cash generation on a per-share basis.
The cash per share value, 5.67, showcases liquidity position.
cards.indicator
cards.value
Operating Cash Flow per Share
-17.89
Free Cash Flow per Share
-17.89
Cash per Share
5.67
Free Cash Flow to Operating Cash Flow Ratio
1.00
Debt and Leverage Ratios
An interest coverage of -16.77 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Interest Coverage
-16.77
Company Equity Multiplier
1.29
Per Share Data
Net income per share, -34.01, reflects the portion of profit attributed to each share.
The book value per share, 11.05, represents the net asset value distributed per share, while the tangible book value per share, 11.05, excludes intangible assets.
cards.indicator
cards.value
Net Income Per Share
-34.01
Book Value Per Share
11.05
Tangible Book Value Per Share
11.05
Shareholders Equity Per Share
11.05
Growth Ratios
EBIT growth, -157.24%, and operating income growth, -157.24%, offer insights into operational profitability progression.
The net income growth, -1385.86%, showcases bottom-line expansion, and the EPS growth, -332.63%, measures the growth in earnings per share.
cards.indicator
cards.value
EBIT Growth
-157.24%
Operating Income Growth
-157.24%
Net Income Growth
-1385.86%
EPS Growth
-332.63%
EPS Diluted Growth
-332.63%
Weighted Average Shares Growth
452.86%
Weighted Average Shares Diluted Growth
452.86%
Operating Cash Flow Growth
-167.90%
Free Cash Flow Growth
-167.90%
10-Year Operating CF Growth per Share
43.40%
5-Year Operating CF Growth per Share
40.72%
3-Year Operating CF Growth per Share
-3.18%
10-Year Net Income Growth per Share
66.99%
5-Year Net Income Growth per Share
48.56%
3-Year Net Income Growth per Share
77.39%
10-Year Shareholders Equity Growth per Share
112.83%
5-Year Shareholders Equity Growth per Share
108.61%
3-Year Shareholders Equity Growth per Share
100.98%
Receivables Growth
-43.29%
Inventory Growth
43.29%
Asset Growth
-56.00%
Book Value per Share Growth
-91.16%
R&D Expense Growth
337.40%
SGA Expenses Growth
20.84%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, -1,837,189.76, captures the company's total value, considering both debt and equity.
Income quality, 1.07, assesses the reliability of reported earnings.
cards.indicator
cards.value
Enterprise Value
-1,837,189.76
Income Quality
1.07
Graham Number
91.93
Return on Tangible Assets
-239.41%
Graham Net Net
8.65
Working Capital
2,906,361
Tangible Asset Value
2,906,361
Net Current Asset Value
2,906,361
Average Receivables
454,377
Average Payables
180,775.231
Average Inventory
-454,377
ROIC
-324.06%
ROE
-3.08%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.33, and the price to book ratio, 0.33, reflect the market's valuation relative to the company's book value.
Ratios like price to free cash flows, -0.17, and price to operating cash flows, -0.10, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
0.33
Price to Book Ratio
0.33
Price Cash Flow Ratio
-0.10
Enterprise Value Multiple
-0.47
Price Fair Value
0.33
Price to Operating Cash Flow Ratio
-0.10
Price to Free Cash Flows Ratio
-0.17
Price to Tangible Book Ratio
0.41
Enterprise Value Over EBITDA
0.19
EV to Operating Cash Flow
0.19
Earnings Yield
-752.39%
Free Cash Flow Yield
-803.44%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
